Valuation: Photonstar Led Group PLC

Market Cap 5.71K 4.96K 4.63K 4.25K 8.02K 544K 8.16K 54.6K 21.38K 271K 21.44K 20.96K 895K P/E 2019
-0.01x
P/E 2020 -0.02x
Enterprise Value -78.29K -68.04K -63.53K -58.32K -110K -7.46M -112K -749K -293K -3.72M -294K -288K -12.27M EV / Sales 2019
-
EV / Sales 2020 -
Free-Float
76.48%
Yield 2019 *
-
Yield 2020 -
Manager TitleAgeSince
Director of Finance/CFO 65 2021-05-13
Chief Tech/Sci/R&D Officer 61 2025-01-01
Director TitleAgeSince
Director/Board Member 45 2019-01-28
Chairman 70 2019-05-20
Director/Board Member 61 2021-05-13
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-99.07% - - 3.54M
+1.86%-0.44%+9.73%+101.26% 9.95B
-1.72%-9.95%+264.67% - 2.34B
-0.13%+7.23%-28.73%-46.35% 2.05B
+2.36%+4.16%-4.62%-13.70% 1.95B
+1.00%+4.11%-21.15%-10.74% 1B
+3.12%+3.74%+34.07%+93.27% 859M
-0.57%0.00%+51.74%+12.58% 734M
+4.00%+0.90%+30.52%+71.48% 582M
+1.15%+1.92%-8.93%+4.13% 561M
Average +1.11%+2.61%+36.37%+26.49% 2.22B
Weighted average by Cap. +1.25%+1.21%+35.30%+57.00%

Financials

2019 2020
Net sales - -
Net income -832K -723K -675K -620K -1.17M -79.3M -1.19M -7.96M -3.12M -39.55M -3.13M -3.06M -130M -306K -266K -248K -228K -430K -29.17M -437K -2.93M -1.15M -14.54M -1.15M -1.12M -47.97M
Net Debt -378K -329K -307K -282K -531K -36.03M -540K -3.62M -1.42M -17.97M -1.42M -1.39M -59.26M -84K -73K -68.16K -62.57K -118K -8.01M -120K -804K -315K -3.99M -316K -309K -13.17M
Logo Photonstar Led Group PLC
Cizzle Biotechnology Holdings PLC is a United Kingdom-based diagnostics developer of early cancer tests. The Company is focused on early detection of lung cancer via the development of an immunoassay test for the CIZ1B biomarker. CIZ1B is a variant of CIZ1, a naturally occurring cell nuclear protein involved in protecting deoxyribonucleic acid (DNA). Its CIZ1B biomarker detects lung cancer at its earliest and most treatable stage. It is designed as a simple blood test, which enables early diagnosis before symptoms appear-when treatment options can transform outcomes for patients and families.
Employees
-